Iterum Therapeutics plc

NasdaqCM:ITRM Stock Report

Market Cap: US$38.0m

Iterum Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ITRM?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders411,2251.19%
Institutions2,786,6618.06%
General Public31,383,51990.8%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 108.9%.

Top Shareholders

Top 25 shareholders own 9.25% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.18%
Armistice Capital LLC
1,445,158US$1.6m7.85%0.04%
1.27%
Renaissance Technologies LLC
438,816US$482.7k0%no data
1%
New Leaf Venture Partners, LLC
345,020US$379.5k0%0.95%
0.72%
Apollon Financial, LLC
250,250US$275.3k0%0.06%
0.64%
Michael Dunne
220,001US$242.0k0%no data
0.4%
Corey Fishman
137,062US$150.8k0%no data
0.29%
OneDigital Investment Advisors, LLC
101,000US$111.1k0%no data
0.2%
Creative Financial Designs Inc, Asset Management Arm
69,947US$76.9k16.8%0.01%
0.073%
Two Sigma Investments, LP
25,245US$27.8k0%no data
0.061%
Citadel Advisors LLC
21,207US$23.3k0%no data
0.058%
Sanctuary Advisors, LLC
20,000US$22.0k0%no data
0.054%
Beth Hecht
18,839US$20.7k0%no data
0.046%
Lee Financial Company, LLC
16,000US$17.6k0%no data
0.043%
Alpine Global Management, LLC
15,000US$16.5k-76.9%0.01%
0.041%
Ronald Hunt
14,346US$15.8k0%no data
0.036%
Geode Capital Management, LLC
12,370US$13.6k0%no data
0.034%
Morgan Stanley, Investment Banking and Brokerage Investments
11,729US$12.9k114%no data
0.03%
Sailaja Puttagunta
10,369US$11.4k0%no data
0.03%
Jane Street Group, LLC, Asset Management Arm
10,262US$11.3k0%no data
0.024%
Judith Matthews
8,135US$8.9k0%no data
0.0089%
UBS Asset Management AG
3,074US$3.4k307,000%no data
0.0072%
David Kelly
2,473US$2.7k0%no data
0.0021%
Tower Research Capital Europe Limited
710US$779.80%no data
0.0014%
Barclays PLC Private Banking & Investment Banking Investment
500US$551.60%no data
0.00038%
Activest Wealth Management, LLC
133US$144.60%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/05 10:34
End of Day Share Price 2025/05/02 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Iterum Therapeutics plc is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Adnan ButtGuggenheim Securities, LLC
Antonio ArceH.C. Wainwright & Co.
Ami FadiaLeerink Partners LLC